Zhu, X., Chen, L., Huang, B., Li, X., Yang, L., Hu, X., . . . Wang, Z. (2021). Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer. J Exp Clin Cancer Res.
Chicago Style CitationZhu, Xiuzhi, Li Chen, Binhao Huang, Xiaoguang Li, Liu Yang, Xin Hu, Yizhou Jiang, Zhimin Shao, i Zhonghua Wang. "Efficacy and Mechanism of the Combination of PARP and CDK4/6 Inhibitors in the Treatment of Triple-negative Breast Cancer." J Exp Clin Cancer Res 2021.
Cita MLAZhu, Xiuzhi, et al. "Efficacy and Mechanism of the Combination of PARP and CDK4/6 Inhibitors in the Treatment of Triple-negative Breast Cancer." J Exp Clin Cancer Res 2021.
Atenció: Aquestes cites poden no estar 100% correctes.